3,4-dihydroxyphenylacetic acid has been researched along with am 404 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Miguel, R; Fernández-Ruiz, JJ; González, S; Lastres-Becker, I; Makriyannis, A; Ramos, JA; Romero, J; Villanua, MA | 1 |
| de Miguel, R; De Petrocellis, L; Di Marzo, V; Fernández-Ruiz, J; Lastres-Becker, I; Makriyannis, A | 1 |
2 other study(ies) available for 3,4-dihydroxyphenylacetic acid and am 404
| Article | Year |
|---|---|
Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Arachidonic Acids; Basal Ganglia; Biological Transport, Active; Carrier Proteins; Chromatography, High Pressure Liquid; Dopamine; Electrochemistry; Endocannabinoids; Extrapyramidal Tracts; gamma-Aminobutyric Acid; Glutamate Decarboxylase; Hypothalamo-Hypophyseal System; Luteinizing Hormone; Male; Neurosecretory Systems; Pituitary-Adrenal System; Polyunsaturated Alkamides; Prolactin; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1999 |
Compounds acting at the endocannabinoid and/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington's disease.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amino Acids, Neutral; Animals; Arachidonic Acids; Basal Ganglia; Cannabinoid Receptor Modulators; Capsaicin; Corpus Striatum; Cyclohexanols; Disease Models, Animal; Dopamine; Endocannabinoids; gamma-Aminobutyric Acid; Huntington Disease; Hyperkinesis; Male; Motor Activity; Nitro Compounds; Palmitates; Piperidines; Propionates; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Rimonabant | 2003 |